George E. Pentheroudakis

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. George Fountzilas · 4 shared papers, 2016–2026 · strength 0.44
   • Paper Phase Ib-II study of ramucirumab combined with nab-paclitaxel and Gemcitabine as first-line treatment in patients with … DOI 10.1016/j.ctarc.2026.101481↗
   • Paper Genetic mapping of pancreatic cancer by targeted next-generation sequencing in a cohort of patients managed with nab-pa… DOI 10.1136/esmoopen-2019-000525↗
   • Paper Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in Patients with Locally Advanced or Metastatic Pancreatic Ca… DOI 10.1007/s11523-018-0605-y↗
2. George Papaxoinis · 2 shared papers, 2016–2026 · strength 0.30
   • Paper Phase Ib-II study of ramucirumab combined with nab-paclitaxel and Gemcitabine as first-line treatment in patients with … DOI 10.1016/j.ctarc.2026.101481↗
   • Paper Expression Patterns of Growth and Survival Genes with Prognostic Implications in Advanced Pancreatic Cancer. DOI 10.21873/anticanres.11232↗
3. Ioannis Kotsantis · 1 shared paper, 2026 · strength 0.25
   • Paper Phase Ib-II study of ramucirumab combined with nab-paclitaxel and Gemcitabine as first-line treatment in patients with … DOI 10.1016/j.ctarc.2026.101481↗
4. Elena Fountzilas · 1 shared paper, 2026 · strength 0.25
   • Paper Phase Ib-II study of ramucirumab combined with nab-paclitaxel and Gemcitabine as first-line treatment in patients with … DOI 10.1016/j.ctarc.2026.101481↗
5. Christos Dervenis · 4 shared papers, 2014–2019 · strength 0.25
   • Paper Genetic mapping of pancreatic cancer by targeted next-generation sequencing in a cohort of patients managed with nab-pa… DOI 10.1136/esmoopen-2019-000525↗
   • Paper Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in Patients with Locally Advanced or Metastatic Pancreatic Ca… DOI 10.1007/s11523-018-0605-y↗
   • Paper Economic Evaluation of NAB-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone for The Management of Metastatic Pancre… DOI 10.1016/j.jval.2014.08.2263↗
6. Dimitrios G. Pectasides · 3 shared papers, 2016–2019 · strength 0.19
   • Paper Genetic mapping of pancreatic cancer by targeted next-generation sequencing in a cohort of patients managed with nab-pa… DOI 10.1136/esmoopen-2019-000525↗
   • Paper Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in Patients with Locally Advanced or Metastatic Pancreatic Ca… DOI 10.1007/s11523-018-0605-y↗
   • Paper Expression Patterns of Growth and Survival Genes with Prognostic Implications in Advanced Pancreatic Cancer. DOI 10.21873/anticanres.11232↗
7. Krittiya Korphaisarn · 1 shared paper, 2025 · strength 0.17
   • Paper Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancrea… DOI 10.1016/j.esmoop.2025.105826↗
8. Thierry Conroy · 1 shared paper, 2025 · strength 0.17
   • Paper Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancrea… DOI 10.1016/j.esmoop.2025.105826↗
9. Cosmas Rinaldi Adithya Lesmana · 1 shared paper, 2025 · strength 0.17
   • Paper Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancrea… DOI 10.1016/j.esmoop.2025.105826↗
10. Wen‐Chi Chou · 1 shared paper, 2025 · strength 0.17
    • Paper Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancrea… DOI 10.1016/j.esmoop.2025.105826↗
11. Myung Ah Lee · 1 shared paper, 2025 · strength 0.17
    • Paper Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancrea… DOI 10.1016/j.esmoop.2025.105826↗
12. Chunyi Hao · 1 shared paper, 2025 · strength 0.17
    • Paper Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancrea… DOI 10.1016/j.esmoop.2025.105826↗
13. Glenn Kunnath Bonney · 1 shared paper, 2025 · strength 0.17
    • Paper Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancrea… DOI 10.1016/j.esmoop.2025.105826↗
14. Akihiro Ohba · 1 shared paper, 2025 · strength 0.17
    • Paper Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancrea… DOI 10.1016/j.esmoop.2025.105826↗
15. Hei‐Cheul Jeung · 1 shared paper, 2025 · strength 0.17
    • Paper Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancrea… DOI 10.1016/j.esmoop.2025.105826↗
16. Li‐Tzong Chen · 1 shared paper, 2025 · strength 0.17
    • Paper Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancrea… DOI 10.1016/j.esmoop.2025.105826↗
17. Andrès M.R. Cervantes · 1 shared paper, 2025 · strength 0.17
    • Paper Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancrea… DOI 10.1016/j.esmoop.2025.105826↗
18. Makoto Ueno · 1 shared paper, 2025 · strength 0.17
    • Paper Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancrea… DOI 10.1016/j.esmoop.2025.105826↗
19. Michel Pierre Ducreux · 1 shared paper, 2025 · strength 0.17
    • Paper Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancrea… DOI 10.1016/j.esmoop.2025.105826↗
20. David Wai-Meng Tai · 1 shared paper, 2025 · strength 0.17
    • Paper Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancrea… DOI 10.1016/j.esmoop.2025.105826↗
21. Lei Wang · 1 shared paper, 2025 · strength 0.17
    • Paper Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancrea… DOI 10.1016/j.esmoop.2025.105826↗
22. Florian Lordick · 1 shared paper, 2020 · strength 0.16
    • Paper ESMO Management and treatment adapted recommendations in the COVID-19 era: Pancreatic Cancer. DOI 10.1136/esmoopen-2020-000804↗
23. Silvia Catanese · 1 shared paper, 2020 · strength 0.16
    • Paper ESMO Management and treatment adapted recommendations in the COVID-19 era: Pancreatic Cancer. DOI 10.1136/esmoopen-2020-000804↗
24. Vasilios Karavasilis · 2 shared papers, 2018–2019 · strength 0.14
    • Paper Genetic mapping of pancreatic cancer by targeted next-generation sequencing in a cohort of patients managed with nab-pa… DOI 10.1136/esmoopen-2019-000525↗
    • Paper Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in Patients with Locally Advanced or Metastatic Pancreatic Ca… DOI 10.1007/s11523-018-0605-y↗
25. Davide N. Mauri · 1 shared paper, 2019 · strength 0.10
    • Paper Microvessel Density and Impact of Angiogenesis on Survival of Resected Pancreatic Cancer Patients: A Systematic Review … DOI 10.1097/mpa.0000000000001237↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.